| Product Code: ETC7039247 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Angina Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Angina Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Angina Market - Industry Life Cycle |
3.4 Egypt Angina Market - Porter's Five Forces |
3.5 Egypt Angina Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Egypt Angina Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Egypt Angina Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Egypt Angina Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Egypt |
4.2.2 Growing adoption of unhealthy lifestyle habits leading to higher incidences of angina |
4.2.3 Rising awareness about the importance of early diagnosis and treatment of angina |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities and services in certain regions of Egypt |
4.3.2 High costs associated with angina treatment and medications |
4.3.3 Lack of trained healthcare professionals specializing in cardiovascular diseases |
5 Egypt Angina Market Trends |
6 Egypt Angina Market, By Types |
6.1 Egypt Angina Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Egypt Angina Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Egypt Angina Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.1.4 Egypt Angina Market Revenues & Volume, By Nitrates and Calcium Channel Blockers, 2021- 2031F |
6.1.5 Egypt Angina Market Revenues & Volume, By Angiotensin-Converting Enzyme Inhibitors, 2021- 2031F |
6.1.6 Egypt Angina Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Egypt Angina Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Egypt Angina Market Revenues & Volume, By Stable Angina and Unstable Angina, 2021- 2031F |
6.2.3 Egypt Angina Market Revenues & Volume, By Variant (Prinzmetal) Angina, 2021- 2031F |
6.2.4 Egypt Angina Market Revenues & Volume, By Microvascular Angina, 2021- 2031F |
6.3 Egypt Angina Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Egypt Angina Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Egypt Angina Market Revenues & Volume, By Cardiology Centers, 2021- 2031F |
6.3.4 Egypt Angina Market Revenues & Volume, By Others, 2021- 2031F |
7 Egypt Angina Market Import-Export Trade Statistics |
7.1 Egypt Angina Market Export to Major Countries |
7.2 Egypt Angina Market Imports from Major Countries |
8 Egypt Angina Market Key Performance Indicators |
8.1 Average waiting time for angina patients to receive medical consultation |
8.2 Percentage of angina patients undergoing regular cardiac screenings |
8.3 Number of public health campaigns promoting awareness about angina and its risk factors |
9 Egypt Angina Market - Opportunity Assessment |
9.1 Egypt Angina Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Egypt Angina Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Egypt Angina Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Egypt Angina Market - Competitive Landscape |
10.1 Egypt Angina Market Revenue Share, By Companies, 2024 |
10.2 Egypt Angina Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here